Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Jiaoshun Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5004080816. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 8

  1. Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer. Co-author DOI 10.1002/advs.202521844↗
  2. Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2026.05.012↗
  3. Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance. Co-author DOI 10.1186/s40164-026-00756-6↗
  4. Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer. Co-author DOI 10.7150/ijbs.125330↗
  5. Single dual-specific anti-PD-L1/TGF-β antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experi… First author DOI 10.1097/js9.0000000000001226↗
  6. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner. Co-author DOI 10.1016/j.canlet.2023.216222↗
  7. Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway. Co-author DOI 10.1016/j.jcmgh.2022.07.008↗
  8. A nomogram predicting overall survival for metastatic pancreatic cancer: SEER database analysis First author DOI 10.21203/rs.3.rs-1410601/v1↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Yin · 5 shared papers, 2022–2026 · strength 1.04
  2. Haoxiang Zhang · 5 shared papers, 2022–2026 · strength 1.04
  3. Chen Chen · 2 shared papers, 2026 · strength 0.48
  4. Rong Tang · 2 shared papers, 2026 · strength 0.48
  5. Liquan Jin · 2 shared papers, 2026 · strength 0.48
  6. Xianjun Yu · 2 shared papers, 2026 · strength 0.48
  7. Shihong Wu · 2 shared papers, 2022–2023 · strength 0.34
  8. Heshui Wu · 2 shared papers, 2022 · strength 0.32
  9. Chuanbing Zhao · 1 shared paper, 2026 · strength 0.32
  10. Tao Yin · 1 shared paper, 2026 · strength 0.32
  11. Qingke Duan · 1 shared paper, 2026 · strength 0.32
  12. S. Y. Shi · 1 shared paper, 2026 · strength 0.26
  13. Miaoyan Wei · 1 shared paper, 2026 · strength 0.26
  14. Yingna Liao · 1 shared paper, 2026 · strength 0.26
  15. Junyi Xu · 1 shared paper, 2026 · strength 0.26
  16. Haoyu Wang · 1 shared paper, 2026 · strength 0.23
  17. Jin Xu · 1 shared paper, 2026 · strength 0.23
  18. Qiong Du · 1 shared paper, 2026 · strength 0.23
  19. Zeyin Rong · 1 shared paper, 2026 · strength 0.23
  20. Si Shi · 1 shared paper, 2026 · strength 0.23
  21. Kun Liu · 1 shared paper, 2022 · strength 0.16
  22. Taoyu Chen · 1 shared paper, 2022 · strength 0.16
  23. Hehe Li · 1 shared paper, 2022 · strength 0.15
  24. Zibo Meng · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.